REXISTA OM Canadian Trademark Information
Drug delivery systems, namely controlled timed release or targeted release pharmaceutical formulations provided as an integral component of pharmaceutical preparations; drug delivery systems, namely controlled timed released or targeted release pharmaceutical preparations, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations; pharmaceutical preparations incorporating controlled timed release or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, all for the use in the treatment of attention deficit disorders, central nervous systems disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders , hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis. Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release or targeted release pharmaceutical preparations.
Perfect for these industries
Words that describe this mark
drug delivery systems controlled timed release targeted release pharmaceutical formulations provided integral component pharmaceutical preparations drug delivery systems controlled timed released targeted release pharmaceutical preparations nature oral solid dose tablets capsules provided integral
Abandonment Notice!
On Wednesday, October 24, 2018,
status on the REXISTA OM
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Tuesday, October 6, 2015, a canadian trademark registration was filed for
REXISTA OM by Intellipharmaceutics Corp *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1749215.
The current status of this trademark filing is Interruption of proceeding.
The REXISTA OM
trademark is filed in the description of
Drug delivery systems, namely controlled timed release or targeted release pharmaceutical formulations provided as an integral component of pharmaceutical preparations; drug delivery systems, namely controlled timed released or targeted release pharmaceutical preparations, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations; pharmaceutical preparations incorporating controlled timed release or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, all for the use in the treatment of attention deficit disorders, central nervous systems disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders , hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis.
,
Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release or targeted release pharmaceutical preparations.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.